US agency accuses L'Oreal of misleading marketing

September 12, 2012

US regulators accused French cosmetics giant L'Oreal of misleading claims in marketing its Lancome line of anti-aging products, according to a letter released Tuesday.

In the letter, addressed to the president of L'Oreal-owned Lancome USA, the said some Lancome products advertised online carry claims that "are intended to affect the structure or any function of the , rendering them drugs" under US law.

The products under scrutiny include the Genifique Youth Activating Concentrate, which claims to boost "the activity of genes and stimulates the production of youth proteins," according to the letter.

Another singled out is the Genifique Repair Youth Activating Night Cream, which claims to boost "the activity of ."

Lancome has 15 days to respond to the FDA warning with specific steps it has taken to correct the violations, according to the letter dated Friday.

"We request that you take prompt action to correct all violations associated with your products, including the violations identified in this letter," wrote the FDA's Michael W. Roosevelt of the Center for and Applied Nutrition. "Failure to do so may result in enforcement action without further notice."

L'Oreal is the world's largest cosmetics maker.

Related Stories

Recommended for you

Re-framing the placebo effect and informed consent

October 29, 2015

(Medical Xpress)—Imagine that your doctor knows from evidence-based studies that if he tells you about certain, small side-effects to a particular drug, you are significantly more likely to experience that side effect than ...

Can exercise be replaced with a pill?

October 2, 2015

Everyone knows that exercise improves health, and ongoing research continues to uncover increasingly detailed information on its benefits for metabolism, circulation, and improved functioning of organs such as the heart, ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.